SynThera Biomedical Company Profile

Background

Company Overview

SynThera Biomedical Private Limited, established in 2015 in Pune, India, is a pioneering enterprise specializing in the research, development, manufacturing, and commercialization of bioactive glass-based biomaterials. The company's mission is to revolutionize the specialty glass industry by delivering high-quality, affordable, and innovative glass products that meet the evolving needs of customers through expertise in material science and a relentless commitment to excellence. SynThera's vision is to become the global leader in specialty glass products and technologies, recognized for unwavering commitment to innovation, exceptional quality, and the advancement of healthcare and industrial standards worldwide.

Industry Significance

As India's first and only company focusing on glass-based biomaterials, SynThera holds a unique position in the biomedical sector. Its innovative approach addresses critical needs in bone tissue regeneration therapies, dental enamel repair, skin care, and disinfection, thereby contributing significantly to advancements in healthcare materials.

Key Strategic Focus

Core Objectives

• Innovation in Biomaterials: Develop and commercialize cutting-edge bioactive glass products for medical applications.

• Market Expansion: Extend product offerings to sectors such as dental, orthopedic, cosmetics, and water treatment industries.

• Quality and Affordability: Ensure high standards in product quality while maintaining cost-effectiveness.

Areas of Specialization

• Bone Tissue Regeneration: Creating bioactive glass materials that facilitate bone repair and regeneration.

• Dental Applications: Developing products for dental enamel repair and other oral health solutions.

• Skin Care and Repair: Innovating in skincare products that leverage bioactive glass properties.

• Disinfection Solutions: Producing materials aimed at effective disinfection in medical and industrial settings.

Key Technologies Utilized

• Bioactive Glass Technology: Utilizing proprietary glass formulations that interact beneficially with biological tissues.

• Material Science Engineering: Applying advanced engineering principles to develop high-purity glass materials for specialized applications.

Primary Markets Targeted

• Healthcare Sector: Dental and orthopedic surgeries, skincare, and wound healing.

• Cosmetics Industry: Products aimed at enhancing skin health and appearance.

• Water Treatment Industry: Materials designed for effective disinfection and purification processes.

Financials and Funding

Funding History

In July 2018, SynThera Biomedical secured seed funding from equity crowdfunding platform 1Crowd and the Biotechnology Industry Research Assistance Council (BIRAC) SEED scheme via Venture Center. The investment aimed to support the expansion, regulatory approvals, and market launch of the company's initial line of bone graft substitute products.

Utilization of Capital

The funds were allocated towards:

• Product Development: Advancing the development and testing of patented bone graft products.

• Regulatory Approvals: Navigating the necessary regulatory pathways for product commercialization.

• Market Launch: Introducing flagship products, SynOst and PoroSyn, to the market.

Pipeline Development

Key Products

• SynOst: A synthetic bone graft substitute made from bioactive glass, intended for use in dental and orthopedic surgeries to repair and regenerate bone lost or damaged due to disease, injuries, or congenital deformities.

• PoroSyn: Another bioactive glass-based bone graft substitute designed for similar applications as SynOst.

Development Stages and Timelines

• SynOst: Targeted for market launch by December 2018.

• PoroSyn: Planned for release by May 2019.

These timelines were set to ensure timely availability of the products to meet market demands.

Technological Platform and Innovation

Proprietary Technologies

• Bioactive Glass Formulations: Developed unique glass compositions that interact positively with biological tissues, promoting healing and regeneration.

Significant Scientific Methods

• Material Science Integration: Combining principles of biology, material science, and engineering to create synergistic therapeutic products.

Leadership Team

Dr. Nilay Lakhkar – Founder and CEO

Dr. Lakhkar established SynThera Biomedical in 2015 after returning from Germany, where he was a postdoctoral researcher at Helmholtz Zentrum Geesthacht Institute of Biomaterials Science. He holds MSc and PhD degrees in Biomaterials and Tissue Engineering from University College London, focusing on bioactive glass materials for orthopedic, dental, and maxillofacial applications. His undergraduate degree is in Chemical Engineering from the University of Mumbai. Dr. Lakhkar brings a strong background in engineering and materials science, with a special focus on healthcare materials, and currently manages the company’s overall functioning and strategic direction.

Deepti Lakhkar – General Manager, Corporate and Commercial

Deepti Lakhkar has a strong legal background with a focus on Company Law. She is a qualified lawyer with advanced degrees in Law and Legal Science from the University of Mumbai and is a qualified company secretary from the Institute of Company Secretaries of India. Prior to joining SynThera, she worked at a renowned Mumbai-based law firm. As one of the earliest team members at SynThera, she complements the technical team with her expertise in strategic, legal, financial, statutory, and HR matters.

Competitor Profile

Market Insights and Dynamics

The global biomaterials market is experiencing significant growth, driven by advancements in medical technologies and an increasing demand for innovative solutions in bone regeneration and repair. The market is characterized by rapid technological developments and a competitive landscape with numerous players striving to introduce novel products.

Competitor Analysis

While specific competitors are not detailed in the available information, SynThera's focus on bioactive glass-based biomaterials positions it uniquely in the market. The company's proprietary technologies and commitment to quality and affordability provide a competitive edge in addressing the needs of dental and orthopedic surgeons.

Strategic Collaborations and Partnerships

SynThera Biomedical has engaged in strategic collaborations to bolster its market position and innovation capacity:

• 1Crowd: An equity crowdfunding platform that provided seed funding, offering not only capital but also access to a network of investors, mentors, and industry connections.

• Venture Center: An incubator that supported SynThera through the BIRAC SEED scheme, facilitating faster progress towards regulatory approvals, production, and sales.

Operational Insights

SynThera's strategic considerations include:

• Quality Assurance: Maintaining high standards in product development to meet regulatory requirements and customer expectations.

• Affordability: Ensuring cost-effective solutions to enhance accessibility and market penetration.

• Innovation: Continuously investing in research and development to stay ahead in the competitive biomaterials market.

Strategic Opportunities and Future Directions

SynThera Biomedical aims to:

• Expand Product Portfolio: Introduce new bioactive glass-based products for various medical applications.

• Enter New Markets: Explore opportunities in international markets to broaden the company's reach.

• Enhance Technological Capabilities: Invest in advanced technologies to improve product efficacy and develop innovative solutions.

Contact Information

Website: synthera.in

Social Media:

• LinkedIn: SynThera Biomedical

• Twitter: @SynTheraBio

• Facebook: SynThera Biomedical